Zeria to pay $128 million for Tillotts Pharma
This article was originally published in Scrip
Executive Summary
The mid-sized Japanese company Zeria has agreed to acquire 100% of the private Swiss firm Tillotts Pharma for SwFr136 million ($128 million). The transaction is expected to close next month and will strengthen Zeria's strategic focus on the gastrointestinal sector.